139 related articles for article (PubMed ID: 8617299)
1. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: evidence for a T helper 2-mediated condition.
Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M; Pizzolo G
Eur J Immunol; 1996 Feb; 26(2):329-34. PubMed ID: 8617299
[TBL] [Abstract][Full Text] [Related]
2. In vitro cell death of activated lymphocytes in Omenn's syndrome.
Brugnoni D; Airò P; Facchetti F; Blanzuoli L; Ugazio AG; Cattaneo R; Notarangelo LD
Eur J Immunol; 1997 Nov; 27(11):2765-73. PubMed ID: 9394797
[TBL] [Abstract][Full Text] [Related]
3. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones.
Piccinni MP; Giudizi MG; Biagiotti R; Beloni L; Giannarini L; Sampognaro S; Parronchi P; Manetti R; Annunziato F; Livi C
J Immunol; 1995 Jul; 155(1):128-33. PubMed ID: 7541410
[TBL] [Abstract][Full Text] [Related]
4. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
5. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells.
D'Elios MM; Romagnani P; Scaletti C; Annunziato F; Manghetti M; Mavilia C; Parronchi P; Pupilli C; Pizzolo G; Maggi E; Del Prete GF; Romagnani S
J Leukoc Biol; 1997 May; 61(5):539-44. PubMed ID: 9129201
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines.
Del Prete G; De Carli M; Almerigogna F; Daniel CK; D'Elios MM; Zancuoghi G; Vinante F; Pizzolo G; Romagnani S
FASEB J; 1995 Jan; 9(1):81-6. PubMed ID: 7821763
[TBL] [Abstract][Full Text] [Related]
7. CD30 and type 2 T helper (Th2) responses.
Romagnani S; Del Prete G; Maggi E; Chilosi M; Caligaris-Cappio F; Pizzolo G
J Leukoc Biol; 1995 May; 57(5):726-30. PubMed ID: 7759952
[TBL] [Abstract][Full Text] [Related]
8. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis.
Mavalia C; Scaletti C; Romagnani P; Carossino AM; Pignone A; Emmi L; Pupilli C; Pizzolo G; Maggi E; Romagnani S
Am J Pathol; 1997 Dec; 151(6):1751-8. PubMed ID: 9403725
[TBL] [Abstract][Full Text] [Related]
9. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
10. CD30 expression does not discriminate between human Th1- and Th2-type T cells.
Hamann D; Hilkens CM; Grogan JL; Lens SM; Kapsenberg ML; Yazdanbakhsh M; van Lier RA
J Immunol; 1996 Feb; 156(4):1387-91. PubMed ID: 8568238
[TBL] [Abstract][Full Text] [Related]
11. Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome.
Rieux-Laucat F; Bahadoran P; Brousse N; Selz F; Fischer A; Le Deist F; De Villartay JP
J Clin Invest; 1998 Jul; 102(2):312-21. PubMed ID: 9664072
[TBL] [Abstract][Full Text] [Related]
12. Plasma soluble CD30 level correlates negatively with age in children.
Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
[TBL] [Abstract][Full Text] [Related]
13. ATG induction therapy: long-term effects on Th1 but not on Th2 responses.
Weimer R; Staak A; Süsal C; Streller S; Yildiz S; Pelzl S; Renner F; Dietrich H; Daniel V; Rainer L; Kamali-Ernst S; Ernst W; Padberg W; Opelz G
Transpl Int; 2005 Feb; 18(2):226-36. PubMed ID: 15691277
[TBL] [Abstract][Full Text] [Related]
14. T helper type 2-like cells and therapeutic effects of interferon-gamma in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).
Schandené L; Ferster A; Mascart-Lemone F; Crusiaux A; Gérard C; Marchant A; Lybin M; Velu T; Sariban E; Goldman M
Eur J Immunol; 1993 Jan; 23(1):56-60. PubMed ID: 8419187
[TBL] [Abstract][Full Text] [Related]
15. Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection.
Vinante F; Krampera M; Morosato L; Rigo A; Romagnani S; Pizzolo G
Haematologica; 1999 Aug; 84(8):683-9. PubMed ID: 10457402
[TBL] [Abstract][Full Text] [Related]
16. Functional heterogeneity among CD4+ T-cell clones from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2.
Howe RC; Wondimu A; Demissee A; Frommel D
Immunology; 1995 Apr; 84(4):585-94. PubMed ID: 7790032
[TBL] [Abstract][Full Text] [Related]
17. Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10.
Mingari MC; Maggi E; Cambiaggi A; Annunziato F; Schiavetti F; Manetti R; Moretta L; Romagnani S
Eur J Immunol; 1996 May; 26(5):1083-7. PubMed ID: 8647171
[TBL] [Abstract][Full Text] [Related]
18. Presence of CD30(+) and CD30L(+) cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy.
Ekström ES; Bengtsson A; Svensson A; Nilsson C; Ostlund E; Sandstedt B; Bremme K; Lilja G; Scheynius A
Placenta; 2001 Apr; 22(4):372-9. PubMed ID: 11286574
[TBL] [Abstract][Full Text] [Related]
19. CD30 expression on allergen- and non-allergen-specific T cell lines and its role in cytokine production.
Tarkowski M
Arch Immunol Ther Exp (Warsz); 2003; 51(5):335-43. PubMed ID: 14626433
[TBL] [Abstract][Full Text] [Related]
20. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
